Alba Therapeutics Corporation Closes on US$30M Series A Financing.BALTIMORE -- Alba Therapeutics Corporation, an early stage biopharmaceutical company focused on zonulin pathway modulation modulation, in communications modulation, in communications, process in which some characteristic of a wave (the carrier wave) is made to vary in accordance with an information-bearing signal wave (the modulating wave); demodulation is the process by which , today announced the closing of its US$30M Series A financing. SV Life Sciences led the investment round together with Alta Partners and are joined by HealthCap, Red Abbey Venture Partners and the Maryland Venture Fund. Additional participants in the round include existing investors Esperance es·per·ance n. Obsolete Hope. [Middle English esperaunce, from Old French, from Vulgar Latin *sp BioVentures, Astellas Ventures, Maryland TEDCO TEDCO Technology Development Corporation (Maryland) TEDCO Toronto Economic Development Corporation (Canada) , and Townsend Capital. "This financing brings together an international group of investors committed to advancing the Company's lead product candidate, AT-1001, through proof-of-concept in humans," said Lutz Giebel, PhD, Venture Partner of SV Life Sciences. "The Company has made outstanding progress in the last twelve months and has met or exceeded all of its development milestones." "This financing supports the vast potential of the zonulin pathway, both for the delivery of drugs and vaccines, and for the treatment of disease states characterized by inappropriate permeability permeability /per·me·a·bil·i·ty/ (per?me-ah-bil´i-te) the property or state of being permeable. per·me·a·bil·i·ty n. 1. The property or condition of being permeable. 2. . The latter includes a significant number of acute and chronic inflammatory and immune conditions, such as Celiac Disease celiac disease: see sprue. celiac disease or nontropical sprue Digestive disorder in which people cannot tolerate gluten, a protein constituent of wheat, barley, malt, and rye flours. and Type 1 Diabetes type 1 diabetes n. See diabetes mellitus. ," said Blake M. Paterson, MD, Alba co-founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "We are honored to have an outstanding group of investors who share our vision and are providing the funding to enable us to move AT-1001 into human trials for Celiac Disease and other autoimmune autoimmune /au·to·im·mune/ (-i-mun´) directed against the body's own tissue; see under disease and response. au·to·im·mune adj. conditions." "Alba's platform is based on more than 10 years of research and an extensive intellectual property foundation licensed from the University of Maryland University of Maryland can refer to:
The Alba Board of Directors consists of: Lutz Giebel, PhD, Venture Partner at SV Life Sciences; Dan Janney, Managing Director at Alta Partners; Magnus Persson, MD, PhD, Partner at HealthCap Venture Capital; Roger Newton, PhD, former President, CEO and co-founder of Esperion Therapeutics, and Blake Paterson, MD, co-founder, President and CEO of Alba. About Alba Alba Therapeutics ("Alba") is a Baltimore-based biopharmaceutical company based at the Emerging Technology Center in Canton. Alba is dedicated to commercializing disease-modifying therapeutics and drug delivery adjuvants based on the zonulin pathway. Alba's lead molecule, AT-1001, is targeted towards the treatment of Celiac Disease and Type 1 Diabetes and is in the final stages of pre-human testing. About SV Life Sciences SV Life Sciences(TM) ("SVLS SVLS Sacramento Valley Live Steamers (Rancho Cordova, CA) ") is a life sciences-focused venture capital adviser and manager. SVLS advised or managed funds invest in companies at all stages of development requiring funding within the human life sciences sector including biotechnology and pharmaceuticals, medical devices and instruments, healthcare IT and services. About Alta Partners Alta Partners is a venture capital firm which funds life sciences and information technology companies. The firm invests in companies across the continuum from early-stage company formation to later-stage opportunities, through separate stage-specific funds. About HealthCap HealthCap is a family of multi stage venture capital funds Venture Capital Funds An investment fund that manages money from investors seeking private equity stakes in small and medium-size enterprises with strong growth potential. Notes: , investing internationally in life sciences, with the Odlander Fredrikson Group as their exclusive investments advisor. HealthCap is the largest specialized provider of venture capital within life sciences in the Nordic countries and one of the largest independent private investors in the sector in Europe. About Red Abbey Red Abbey Venture Partners ("Red Abbey") focuses on investing in high-quality life sciences companies that are developing novel therapeutics and other products based on distinctive technologies. Red Abbey invests in companies at all stages of development. About Maryland Department of Business and Economic Development ("DBED DBED Department of Business and Economic Development (Maryland) DBED Double Bit Error Detecting ") Venture Fund The Maryland DBED Venture Capital Fund was established in 1994 and provides direct equity investments in emerging high technology Maryland companies with patented or proprietary products or manufacturing processes and a marketing strategy in place. The Fund works with established and early stage Maryland companies to move them into their next stage of development as a viable business. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion